REQUEST A DEMO
Total
USD $0.00
Search more companies

Delivery Clinical Studies S.A.S. (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Secondary Activities: All Other Professional, Scientific, and Technical Services
Full name: Delivery Clinical Studies S.A.S. Profile Updated: June 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Delivery Clinical Studies S.A.S. is an enterprise in Colombia, with the main office in Sabaneta. It operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. It was established on September 17, 2021. The total number of employees is currently 13 (2024). From the latest financial highlights, Delivery Clinical Studies S.A.S. reported a net sales revenue increase of 42.51% in 2023. A growth of 21.47% was recorded in its total assets. The net profit margin of Delivery Clinical Studies S.A.S. increased by 4.32% in 2023.

Headquarters
Cr 49 61 Sur 68 To 1 Of 205
Sabaneta; Antioquia;

Contact Details: Purchase the Delivery Clinical Studies S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Delivery Clinical Studies S.A.S. report to view the information.
Outstanding Shares:
Purchase the Delivery Clinical Studies S.A.S. report to view the information.
Incorporation Date:
September 17, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Delivery Clinical Studies S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
42.51%
Total operating revenue
42.51%
Net Profit (Loss) for the Period
123.8%
Total assets
21.47%
Total equity
86.03%
Net Profit Margin
4.32%
Return on Equity (ROE)
7.8%
Quick Ratio
-1.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?